Hye Yeon Chon
0000-0003-4009-8180
Yonsei University College of Medicine
11 papers found
Refreshing results…
Systemic Chemotherapy with Combination of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor in Unresectable Hepatocellular Carcinoma
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
Bile Acids: Major Regulator of the Gut Microbiome
Liver Cirrhosis and Sarcopenia
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
Direct-acting antivirals improve treatment outcomes in patients with chronic hepatitis C-related hepatocellular carcinoma treated with transarterial chemoembolization: a nationwide, multi-center, retrospective cohort study
Advanced liver fibrosis predicts poor cardiovascular outcomes in patients with type 2 diabetes
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
Missing publications? Search for publications with a matching author name.